SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039341
Filing Date
2020-08-11
Accepted
2020-08-11 16:45:46
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q goss-10q_20200630.htm 10-Q 2050763
2 EX-10.2 goss-ex102_35.htm EX-10.2 43644
3 EX-31.1 goss-ex311_9.htm EX-31.1 16894
4 EX-31.2 goss-ex312_6.htm EX-31.2 16917
5 EX-32.1 goss-ex321_7.htm EX-32.1 6969
6 EX-32.2 goss-ex322_11.htm EX-32.2 6951
  Complete submission text file 0001564590-20-039341.txt   7565090

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT goss-20200630.xml EX-101.INS 1542470
8 XBRL TAXONOMY EXTENSION SCHEMA goss-20200630.xsd EX-101.SCH 61440
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE goss-20200630_cal.xml EX-101.CAL 60720
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE goss-20200630_def.xml EX-101.DEF 239911
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE goss-20200630_lab.xml EX-101.LAB 478903
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE goss-20200630_pre.xml EX-101.PRE 368509
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38796 | Film No.: 201093044
SIC: 2834 Pharmaceutical Preparations